A 38-year-old woman is brought to the emergency department due to a 4-day history of worse… — USMLE Step 2 CK

A $38$ -year-old woman is brought to the emergency department due to a $4$ -day history of worsening fatigue, spontaneous bruising, and continuous oozing of blood from her gums. Her temperature is $37.9^\circ\text{C}$ ( $100.2^\circ\text{F}$ ), blood pressure is $110/65 \text{ mm Hg}$ , and pulse is $112/\text{min}$ . Physical examination shows scattered petechiae and large ecchymoses over her extremities.

Laboratory studies reveal the following:

Laboratory Parameter	Patient Value	Reference Range
Hemoglobin	$7.8 \text{ g/dL}$	$12.0-15.5 \text{ g/dL}$
Platelets	$22,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Leukocytes	$1,800/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Prothrombin time (PT)	$19 \text{ sec}$	$11-15 \text{ sec}$
aPTT	$44 \text{ sec}$	$25-40 \text{ sec}$
Fibrinogen	$85 \text{ mg/dL}$	$200-400 \text{ mg/dL}$
D-dimer	$>10,000 \text{ ng/mL}$	$<500 \text{ ng/mL}$

A peripheral blood smear demonstrates pancytopenia and atypical promyelocytes with abundant primary granules and multiple rod-like intracytoplasmic inclusions bundled together.

Arrange the following steps in the most appropriate chronological order for the diagnosis and management of this patient's condition:

1Initiate empiric treatment with all-trans retinoic acid (ATRA) without waiting for molecular confirmation
2Perform bone marrow aspiration and cytogenetic analysis to confirm the $t(15;17)$ translocation
3Incorporate arsenic trioxide (ATO) into the regimen for definitive induction therapy
4Administer high-dose dexamethasone for new-onset dyspnea, fever, and pulmonary infiltrates
5Transition to a long-term maintenance regimen after achieving molecular remission

Answer

The correct sequence is to first initiate empiric ATRA, followed by confirmatory bone marrow testing, addition of ATO for definitive induction, management of potential differentiation syndrome with dexamethasone, and finally transition to maintenance therapy.

The correct sequence of management for acute promyelocytic leukemia (APL) prioritizes the immediate stabilization of life-threatening coagulopathy over definitive diagnostic confirmation. ATRA must be started empirically upon clinical suspicion (DIC plus characteristic faggot cells). This is followed sequentially by confirmatory bone marrow testing, definitive induction therapy with the addition of ATO, management of expected treatment complications like differentiation syndrome, and finally maintenance therapy to prevent relapse.

Step-by-Step Solution

Recognize the clinical presentation of Acute Promyelocytic Leukemia (APL).

The patient has pancytopenia, severe DIC (low fibrinogen, prolonged PT/aPTT, elevated D-dimer), and atypical promyelocytes with bundled Auer rods (faggot cells).

Identifying APL is critical because it is a medical emergency requiring a specific sequence of interventions.

Determine the first and most urgent therapeutic intervention.

Initiate ATRA immediately.

ATRA induces differentiation of leukemic cells, rapidly reversing the life-threatening coagulopathy. It must NOT be delayed for confirmatory testing.

Establish the definitive diagnosis.

Perform bone marrow aspiration and cytogenetic/molecular testing for

t(15;17)

or PML::RARA fusion.

Confirmatory testing is required to guide the full induction regimen, but is done after the initial emergency ATRA dose.

Plan the full induction chemotherapy regimen.

Add Arsenic Trioxide (ATO) or an anthracycline.

Once APL is confirmed, ATRA is combined with ATO to complete the induction phase and achieve remission.

Anticipate and manage induction complications.

Administer dexamethasone for differentiation syndrome.

As promyelocytes differentiate, they release cytokines causing fever, dyspnea, and pulmonary infiltrates (differentiation syndrome), which requires prompt steroid therapy.

Plan post-remission therapy.

Transition to maintenance therapy.

After induction and consolidation phases achieve molecular remission, maintenance therapy prevents relapse.

Key Concept

In patients with suspected acute promyelocytic leukemia (APL) presenting with disseminated intravascular coagulation, empiric all-trans retinoic acid (ATRA) must be initiated immediately prior to obtaining definitive molecular confirmation to prevent fatal hemorrhage.

Estimated Time:2m 0s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic